Neumora Therapeutics, Inc. NMRA Фондовый прогноз
ИИ-прогноз цены и анализ для Neumora Therapeutics, Inc. · Обновленный Апр 02, 2026
ИИ-прогноз на 90 дней
СИЛЬНАЯ ПОКУПКА
7 дней
30 дней
90 дней
Уверенность AI: 39% Корреляция Спирмена
Апрель 02, 2026
Посмотреть точную целевую цену NMRA
Создайте бесплатный аккаунт, чтобы разблокировать ИИ-прогнозы для более 4 000 акций
Зарегистрируйтесь бесплатно через Google✓ Бесплатный аккаунт · ✓ Пробный период 30 дней · ✓ Отмена в любое время
График цен
Загрузка графика...
Ключевые показатели
Рыночная капитализация
$348M
Коэффициент P/E
-3,9x
Коэффициент P/B
3,35x
EPS
$-1,57
О сайте Neumora Therapeutics, Inc.
Neumora Therapeutics, Inc. (NMRA) работает в секторе Life Sciences, в частности в отрасли Biological Products, (No Diagnostic Substances). .
We do not have any company description for Neumora Therapeutics, Inc. at the moment.
Последние новости
- Neumora tops Q4 earnings forecasts as pipeline advances, shares slip
- Neumora Therapeutics Inc (NMRA) Q4 2025 Earnings Call Highlights: Strong Financial Position ...
- Neumora Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
- Зарегистрируйтесь бесплатно, чтобы прочитать все 12 статей →
Biological Products, (No Diagnostic Substances) Сопоставимые компании
| Компания | Тикер | ИИ-сигнал | Рыночная капитализация | P/E |
|---|---|---|---|---|
| Acumen Pharmaceuticals, Inc. | ABOS | ██% | $188M | -1,9x |
| Abpro Holdings, Inc. | ABP | ██% | $310K | -x |
| Abpro Holdings, Inc. | ABPO | ██% | $460K | -x |
| Arcellx, Inc. | ACLX | ██% | $6.65B | -74,1x |
| Alpha Cognition Inc. | ACOG | ██% | $134M | -x |
| Adaptimmune Therapeutics Plc | ADAP | ██% | $77M | -13,2x |
| Adma Biologics, Inc. | ADMA | ██% | $2.17B | 14,8x |
| Adaptive Biotechnologies Corp | ADPT | ██% | $2.25B | -4,6x |
| Adverum Biotechnologies, Inc. | ADVM | ██% | $95M | -1,8x |
| Agenus Inc | AGEN | ██% | $120M | 1047,3x |
| Agentix Corp. | AGTX | ██% | $2M | -x |
| Aim Immunotech Inc. | AIM | ██% | $2M | -0,5x |
| Aim Immunotech Inc. | AIMI | ██% | $1M | -x |
| Alector, Inc. | ALEC | ██% | $251M | -1,2x |
| Aligos Therapeutics, Inc. | ALGS | ██% | $49M | -19,2x |
| Allogene Therapeutics, Inc. | ALLO | ██% | $593M | -1,4x |
| Alvotech | ALVO | ██% | $1.13B | -x |
| Amgen Inc | AMGN | ██% | $190.18B | 24,7x |
| Apogee Therapeutics, Inc. | APGE | ██% | $5.77B | -20,5x |
| Aptose Biosciences Inc. | APTOF | ██% | $4M | -x |
| Argenx Se | ARGX | ██% | $46.03B | -x |
| Armata Pharmaceuticals, Inc. | ARMP | ██% | $378M | -1,0x |
| Artiva Biotherapeutics, Inc. | ARTV | ██% | $165M | -x |
| Leonabio, Inc. | ATHA | ██% | $23M | -0,2x |
| Atara Biotherapeutics, Inc. | ATRA | ██% | $42M | 1,3x |
| Atyr Pharma Inc | ATYR | ██% | $84M | -3,6x |
| Aura Biosciences, Inc. | AURA | ██% | $416M | -4,9x |
| Autolus Therapeutics Plc | AUTL | ██% | $374M | -x |
| Anavex Life Sciences … | AVXL | ██% | $279M | -17,3x |
| Bioatla, Inc. | BCAB | ██% | $11M | -1,1x |
| Biocardia, Inc. | BCDA | ██% | $12M | -0,6x |
| Brainstorm Cell Therapeutics … | BCLI | ██% | $10M | -4,9x |
| Biocryst Pharmaceuticals Inc | BCRX | ██% | $2.35B | 8,9x |
| Black Diamond Therapeutics, … | BDTX | ██% | $133M | 6,0x |
| Beam Therapeutics Inc. | BEAM | ██% | $2.46B | -12,6x |
| Biogen Inc. | BIIB | ██% | $26.98B | 20,9x |
| Biontech Se | BNTX | ██% | $22.47B | -x |
| Cabaletta Bio, Inc. | CABA | ██% | $269M | -1,6x |
| Candel Therapeutics, Inc. | CADL | ██% | $365M | -4,6x |
| C4 Therapeutics, Inc. | CCCC | ██% | $262M | -2,6x |
| Cidara Therapeutics, Inc. | CDTX | ██% | $6.49B | -1,0x |
| Creative Medical Technology … | CELZ | ██% | $7M | -3,4x |
| Cero Therapeutics Holdings, … | CERO | ██% | $650K | -x |
| Cullinan Therapeutics, Inc. | CGEM | ██% | $840M | -4,1x |
| Compugen Ltd | CGEN | ██% | $211M | 3,0x |
| Cg Oncology, Inc. | CGON | ██% | $5.39B | -x |
| Cognition Therapeutics Inc | CGTX | ██% | $76M | -0,5x |
| Coherus Oncology, Inc. | CHRS | ██% | $256M | 1,5x |
| Calidi Biotherapeutics, Inc. | CLDI | ██% | $2M | -0,9x |
| Cellectis S.A. | CLLS | ██% | $344M | -x |
| Compass Therapeutics, Inc. | CMPX | ██% | $968M | -4,8x |
| Mosaic Immunoengineering Inc. | CPMV | ██% | $5M | -x |
| Caribou Biosciences, Inc. | CRBU | ██% | $142M | -1,5x |
| Cardiff Oncology, Inc. | CRDF | ██% | $110M | -4,0x |
| Cardiol Therapeutics Inc. | CRDL | ██% | $156M | -x |
| Curis Inc | CRIS | ██% | $22M | -0,3x |
| Crispr Therapeutics Ag | CRSP | ██% | $4.70B | -12,1x |
| Champions Oncology, Inc. | CSBR | ██% | $82M | 32,9x |
| Cel Sci Corp | CVM | ██% | $29M | -0,9x |
| Dbv Technologies S.A. | DBVT | ██% | $1.24B | -3,3x |
| Dbv Technologies S.A. | DBVTF | ██% | $10K | -x |
| Ginkgo Bioworks Holdings, … | DNA | ██% | $395M | -13,9x |
| Denali Therapeutics Inc. | DNLI | ██% | $3.23B | -8,7x |
| Precision Biosciences Inc | DTIL | ██% | $137M | -2,2x |
| Dyadic International Inc | DYAI | ██% | $31M | -7,3x |
| Editas Medicine, Inc. | EDIT | ██% | $255M | -0,8x |
| Eloxx Pharmaceuticals, Inc. | ELOX | ██% | $710K | -x |
| Elutia Inc. | ELUT | ██% | $45M | 0,9x |
| Engene Holdings Inc. | ENGN | ██% | $453M | 3,7x |
| Entera Bio Ltd. | ENTX | ██% | $53M | 8,5x |
| Viskase Holdings, Inc. | ENZN | ██% | $4M | -x |
| Estrella Immunopharma, Inc. | ESLA | ██% | $45M | -3,1x |
| Evaxion A/S | EVAX | ██% | $33M | -x |
| Exelixis, Inc. | EXEL | ██% | $11.56B | 14,8x |
| Exozymes Inc. | EXOZ | ██% | $71M | -x |
| Fate Therapeutics Inc | FATE | ██% | $143M | -1,3x |
| 4d Molecular Therapeutics, … | FDMT | ██% | $504M | -3,0x |
| Fennec Pharmaceuticals Inc. | FENC | ██% | $219M | 1758,3x |
| Finch Therapeutics Group, … | FNCH | ██% | $15M | 0,5x |
| Futuretech Ii Acquisition … | FTII | ██% | $52M | -x |
| Futuretech Ii Acquisition … | FTIIU | ██% | $14M | -x |
| Gilead Sciences, Inc. | GILD | ██% | $174.11B | 20,5x |
| Monte Rosa Therapeutics, … | GLUE | ██% | $1.37B | 59,5x |
| Genenta Science S.P.A. | GNTA | ██% | $16M | -x |
| Green Planet Bio … | GPLB | ██% | $340K | -x |
| Greenland Mines Ltd | GRML | ██% | $44M | -x |
| Halozyme Therapeutics, Inc. | HALO | ██% | $7.54B | 23,8x |
| Humacyte, Inc. | HUMA | ██% | $131M | -3,3x |
| Immunitybio, Inc. | IBRX | ██% | $7.22B | -3,6x |
| Inhibikase Therapeutics, Inc. | IKT | ██% | $238M | -1,0x |
| Imagenebio, Inc. | IMA | ██% | $56M | -x |
| Immunocore Holdings Plc | IMCR | ██% | $1.54B | -x |
| Immatics N.V. | IMTX | ██% | $1.34B | -x |
| Immunovant, Inc. | IMVT | ██% | $5.06B | -14,5x |
| In8bio, Inc. | INAB | ██% | $14M | -x |
| Inhibrx Biosciences, Inc. | INBX | ██% | $873M | -6,8x |
| Mink Therapeutics, Inc. | INKT | ██% | $45M | -1,5x |
| Inmune Bio, Inc. | INMB | ██% | $33M | -2,5x |
| Intensity Therapeutics, Inc. | INTS | ██% | $14M | -2,2x |
| Iovance Biotherapeutics, Inc. | IOVA | ██% | $1.41B | -4,5x |
| Century Therapeutics, Inc. | IPSC | ██% | $394M | -0,7x |
| Invivyd, Inc. | IVVD | ██% | $360M | -0,4x |
| Jasper Therapeutics, Inc. | JSPR | ██% | $22M | -3,2x |
| Kalaris Therapeutics, Inc. | KLRS | ██% | $136M | -x |
| Klotho Neurosciences, Inc. | KLTO | ██% | $56M | -x |
| Kodiak Sciences Inc. | KOD | ██% | $2.64B | -2,5x |
| Krystal Biotech, Inc. | KRYS | ██% | $7.56B | 36,9x |
| Kymera Therapeutics, Inc. | KYMR | ██% | $6.91B | -17,8x |
| Kyverna Therapeutics, Inc. | KYTX | ██% | $530M | -x |
| Ladrx Corp | LADX | ██% | $20K | -x |
| Lineage Cell Therapeutics, … | LCTX | ██% | $387M | -4,7x |
| Lenz Therapeutics, Inc. | LENZ | ██% | $293M | -6,7x |
| Liminatus Pharma, Inc. | LIMN | ██% | $7M | -x |
| Leonabio, Inc. | LONA | ██% | $106M | -x |
| Lexeo Therapeutics, Inc. | LXEO | ██% | $414M | -0,4x |
| Maze Therapeutics, Inc. | MAZE | ██% | $1.43B | -x |
| Mesoblast Ltd | MESO | ██% | $2.07B | -x |
| Meiragtx Holdings Plc | MGTX | ██% | $737M | -3,4x |
| Metagenomi Therapeutics, Inc. | MGX | ██% | $50M | -x |
| Molecular Partners Ag | MOLN | ██% | $162M | -x |
| Moderna, Inc. | MRNA | ██% | $19.71B | -3,2x |
| Neurocrine Biosciences Inc | NBIX | ██% | $13.27B | 27,7x |
| Nkgen Biotech, Inc. | NKGN | ██% | $2M | -0,1x |
| Neumora Therapeutics, Inc. | NMRA | ██% | $348M | -3,9x |
| Novavax Inc | NVAX | ██% | $1.30B | 3,0x |
| Ocugen, Inc. | OCGN | ██% | $559M | -4,3x |
| Outlook Therapeutics, Inc. | OTLK | ██% | $22M | -0,2x |
| Palisade Bio, Inc. | PALI | ██% | $312M | -0,2x |
| Passage Bio, Inc. | PASG | ██% | $25M | -0,6x |
| Vaxcyte, Inc. | PCVX | ██% | $7.67B | -20,4x |
| Biomx Inc. | PHGE | ██% | $22M | 1,5x |
| Pluri Inc. | PLUR | ██% | $33M | -1,4x |
| Protalix Biotherapeutics, Inc. | PLX | ██% | $176M | 41,2x |
| Pharmacyte Biotech, Inc. | PMCB | ██% | $7M | 0,3x |
| Prime Medicine, Inc. | PRME | ██% | $599M | -1,5x |
| Prokidney Corp. | PROK | ██% | $527M | -x |
| Pelthos Therapeutics Inc. | PTHS | ██% | $66M | -x |
| Qiagen N.V. | QGEN | ██% | $8.86B | -x |
| Quince Therapeutics, Inc. | QNCX | ██% | $5M | -1,7x |
| Qrons Inc. | QRON | ██% | $150K | -x |
| Replimune Group, Inc. | REPL | ██% | $606M | -3,8x |
| Repligen Corp | RGEN | ██% | $6.66B | 136,3x |
| Regenxbio Inc. | RGNX | ██% | $439M | -1,8x |
| Relay Therapeutics, Inc. | RLAY | ██% | $1.87B | -2,0x |
| Revolution Medicines, Inc. | RVMD | ██% | $19.43B | -11,1x |
| Recursion Pharmaceuticals, Inc. | RXRX | ██% | $1.62B | -4,7x |
| Sab Biotherapeutics, Inc. | SABS | ██% | $271M | 20,4x |
| Sana Biotechnology, Inc. | SANA | ██% | $846M | -2,1x |
| Scilex Holding Co | SCLX | ██% | $49M | -0,4x |
| Scinai Immunotherapeutics Ltd. | SCNI | ██% | $2M | -287,8x |
| Sangamo Therapeutics, Inc | SGMO | ██% | $91M | -1,6x |
| Solid Biosciences Inc. | SLDB | ██% | $726M | -0,9x |
| Silexion Therapeutics Corp | SLXN | ██% | $4M | -x |
| Senti Biosciences, Inc. | SNTI | ██% | $26M | -1,1x |
| Scholar Rock Holding … | SRRK | ██% | $5.35B | -18,5x |
| Surrozen, Inc./De | SRZN | ██% | $335M | -0,5x |
| Sutro Biopharma, Inc. | STRO | ██% | $392M | -1,0x |
| Protara Therapeutics, Inc. | TARA | ██% | $270M | -2,1x |
| Tarsus Pharmaceuticals, Inc. | TARS | ██% | $2.99B | -12,4x |
| Tc Biopharm (Holdings) … | TCBPY | ██% | $10K | -x |
| Tscan Therapeutics, Inc. | TCRX | ██% | $57M | -4,6x |
| Bio-Techne Corp | TECH | ██% | $8.34B | 102,8x |
| Tectonic Therapeutic, Inc. | TECX | ██% | $575M | -8,9x |
| Instil Bio, Inc. | TIL | ██% | $54M | -1,1x |
| Tenaya Therapeutics, Inc. | TNYA | ██% | $151M | -2,5x |
| Tourmaline Bio, Inc. | TRML | ██% | $1.23B | -3,5x |
| Taysha Gene Therapies, … | TSHA | ██% | $1.25B | -3,0x |
| Titan Pharmaceuticals Inc | TTNP | ██% | $6M | -0,5x |
| Tevogen Bio Holdings … | TVGN | ██% | $18M | -x |
| Twist Bioscience Corp | TWST | ██% | $3.08B | -12,6x |
| Voyager Acquisition Corp./Cayman … | VACH | ██% | $374M | 41,6x |
| Voyager Acquisition Corp./Cayman … | VACHU | ██% | $68M | 6,7x |
| Valneva Se | VALN | ██% | $530M | -x |
| Vericel Corp | VCEL | ██% | $1.59B | 96,5x |
| Vir Biotechnology, Inc. | VIR | ██% | $1.47B | -2,0x |
| Vivosim Labs, Inc. | VIVS | ██% | $4M | -x |
| Vor Biopharma Inc. | VOR | ██% | $882M | -0,6x |
| Vaxart, Inc. | VXRT | ██% | $151M | 9,3x |
| Voyager Therapeutics, Inc. | VYGR | ██% | $234M | 570,6x |
| Windtree Therapeutics Inc … | WINT | ██% | $340K | -0,4x |
| X4 Pharmaceuticals, Inc | XFOR | ██% | $402M | 6,4x |
| Zeo Scientifix, Inc. | ZEOX | ██% | $17M | -x |
| Zivo Bioscience, Inc. | ZIVO | ██% | $25M | -31,3x |
| Zura Bio Ltd | ZURA | ██% | $559M | -x |
Частые вопросы
-
Стоит ли покупать акции Neumora Therapeutics, Inc.?
Наш ИИ анализирует Neumora Therapeutics, Inc. ежедневно. Проверьте сигнал выше для последней рекомендации. Всегда проводите собственное исследование перед инвестированием.
-
Насколько точны прогнозы Neumora Therapeutics, Inc.?
Наш ИИ достигает корреляции Спирмена 39% для этой акции, со средней точностью выше 67% по более чем 4 000 акциям, анализируемым ежедневно.
-
Как часто обновляются прогнозы?
Прогнозы Neumora Therapeutics, Inc. обновляются ежедневно с использованием последних рыночных данных и ИИ-моделей.
Готовы инвестировать умнее?
Присоединяйтесь к тысячам инвесторов, использующих ИИ-прогнозы акций
Зарегистрироваться бесплатно✓ Бесплатный аккаунт · ✓ Более 4 000 акций · ✓ Ежедневные обновления
Ищете более глубокий анализ Neumora Therapeutics, Inc.?
Посмотреть полный институциональный анализ на Intratio →ИИ-прогнозы основаны на исторических закономерностях и не должны быть единственным основанием для инвестиционных решений. Прошлые результаты не гарантируют будущих доходов. Всегда проводите собственное исследование.